Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Amgen Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 141
» View latimes.com items only
    May 12, 2013 |Story| Los Angeles Times

  1. Lieuwe Westra wins Amgen Tour's first stage under brutal heat

    ESCONDIDO, Calif. — Lieuwe Westra, red-faced and shaking, was the winner of Sunday's first stage at the Amgen Tour of California, on a day when temperatures on the route were recorded as high as 105 degrees.
    ESCONDIDO, Calif. — Lieuwe Westra, red-faced and shaking, was the winner of Sunday's first stage at the Amgen Tour of California, on a day when temperatures on the route were recorded as high as 105 degrees. James Stemper, of the 5-hour Energy/...

    Tags: Peter Sagan, Tour of California, Lieuwe Westra

    2. May 12, 2013 |Story| Los Angeles Times

  2. Bill would regulate 'biosimilar' drugs

    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...

    Tags: Imports, Jerry Hill, Food and Drug Administration, Health and Medical Professionals, Roche Holding AG

    3. May 6, 2013 |Story| Los Angeles Times

  3. Amgen at a glance

    The company: Amgen Inc. Headquarters: Thousand Oaks Ticker: AMGN Employees: 18,000 Leadership: Robert A. Bradway, chief executive since May 2012 2012 revenue: $17.3 billion 2012 net income: $4.3 billion Stock price: $106.48 at Friday's close...
    4. May 6, 2013 |Story| Los Angeles Times

  4. Amgen aims to restock its medicine cabinet

    Amgen Inc. is a biotechnology company that develops medicines used in the treatment of cancer, kidney disease, arthritis, bone disease and other serious illnesses.
    Amgen Inc. is a biotechnology company that develops medicines used in the treatment of cancer, kidney disease, arthritis, bone disease and other serious illnesses. The Thousand Oaks company's top-selling products include arthritis medication Enbrel,...

    Tags: Health Treatments, Enbrel (drug), Diseases and Illnesses, Anemia, Erythropoietin

    5. May 5, 2013 |Story| Los Angeles Times

  5. A wife's Alzheimer's, a husband's obsession

    Ken Chiate is a born problem-solver, and in the summer of 1961, when he was on break from college, his problem was a head-turning blond named Jeannette.
    Ken Chiate is a born problem-solver, and in the summer of 1961, when he was on break from college, his problem was a head-turning blond named Jeannette. He was head lifeguard at a public pool in Phoenix, where his father owned a liquor store. She worked...

    Tags: Radio, Internists, Health and Medical Professionals, Diseases and Illnesses, Justice System

    6. Apr 26, 2013 |Story| Los Angeles Times

  6. L.A. jury finds three guilty in $1.5-million Medicare fraud scheme

    A federal jury in Los Angeles found an Anaheim physician and two others guilty this week for their roles in a $1.5-million Medicare fraud scheme involving power wheelchairs. At trial, federal prosecutors said that Godwin Onyeabor, 49, an officer at...

    Tags: FBI, Trials, Drugs and Medicines, Medicare, General Practitioners

    7. Apr 24, 2013 |Story| Los Angeles Times

  7. Amgen stock drops 7% as revenue misses Wall St. forecasts

    Shares of biotech giant Amgen Inc. slumped as investors reacted to weaker-than-expected first-quarter sales.
    Shares of biotech giant Amgen Inc. slumped as investors reacted to weaker-than-expected first-quarter sales. Shares of the Thousand Oaks company dropped $7.83, or 7%, to $104.93 in trading Wednesday. The company's stock had posted impressive gains until...

    Tags: Enbrel (drug), Rheumatoid Arthritis

    8. Apr 24, 2013 |Story| Los Angeles Times

  8. Shares of biotech giant Amgen slide on disappointing sales

    Shares of biotech giant Amgen Inc. slumped Wednesday as investors reacted to weaker-than-expected first-quarter sales.
    Shares of biotech giant Amgen Inc. slumped Wednesday as investors reacted to weaker-than-expected first-quarter sales. Shares of the Thousand Oaks company dropped $6.41, or nearly 6%, to $106.35 in trading Wednesday. The company's stock had posted...

    Tags: Enbrel (drug), Rheumatoid Arthritis

    9. Apr 11, 2013 |Story| Los Angeles Times

  9. Letters: Medicare and Amgen

    Re "Remove Medicare's straitjacket," Opinion, March 29 Art Kellerman misunderstands why Congress delayed inclusion of oral-only drugs in the Medicare payment bundle for dialysis services. It wasn't to give Amgen and other drug makers a major windfall;...

    Tags: Medicare, Health and Medical Professionals, U.S. Congress, Oral and Maxillofacial Surgeons, Dialysis

    10. Mar 29, 2013 |Story| Los Angeles Times

  10. Remove Medicare's straitjacket

    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although raising the age of Medicare eligibility from 65 to 67 appears off the table, at least for now, the budget plan that Rep. Paul D. Ryan (R-Wis.) is proposing would shift a greater share of the program's growing costs to beneficiaries in the years to come.
    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...

    Tags: Private Health Care, Macular Degeneration, U.S. Congress, Patient Protection and Affordable Care Act, New Products

    11. Mar 17, 2013 |Story| Los Angeles Times

  11. Battle over 'biosimilars'

    One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies what amounts to a 12-year monopoly on the substances they developed. Now, supporters of biologics are pushing lawmakers in Sacramento and other state capitals to put new hurdles in the way of knock-off compounds, called "biosimilars."
    One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies...

    Tags: Prescription Drugs, General Practitioners, Criminal Minds: Suspect Behavior (tv program), Health and Medical Professionals, Justice System

    12. Mar 7, 2013 |Story| Los Angeles Times

  12. Teams announced for 2013 Amgen Tour of California

    Amgen Tour of California announced that 16 teams will participate in the 2013 race that will run from May 12-19.
    Amgen Tour of California announced that 16 teams will participate in the 2013 race that will run from May 12-19. Returning for its sixth year is Belgium team Omega Pharama-Quick Step Cycling, whose roster includes popular sprinter Tom Boonen, whose...

    Tags: Peter Sagan, Road Race Cycling, Trials, Cycling, Philippe Gilbert

 1  2 3 4 5 6 7 8 9 10 11-12 • Next >
Original site for Amgen Inc. topic gallery.
Advertisement
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Amgen Inc. Photos
Thousand Oaks-based biotechnology company Amgen Inc. ha...
(May 14, 2013)
6: Amgen Inc.
Some firms seek to make "biosimilar" drugs that would p...
(April 25, 2013)
Bill would regulate ‘biosimilar’ drugs
Shares in Thousand Oaks-based Amgen Inc. dipped Wednesd...
(April 24, 2013)
Amgen's shares dip on first-quarter results
 » All 19 Amgen Inc. photos